Vivici Picks Ginkgo Bioworks To Extend Their Range Of Novel Dairy Proteins
Portfolio Pulse from Benzinga Newsdesk
Vivici has partnered with Ginkgo Bioworks to develop and commercialize a new generation of functional alternative dairy proteins using Ginkgo's strain engineering and optimization expertise.
November 27, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ginkgo Bioworks, trading under the symbol DNA, is set to collaborate with Vivici to produce alternative dairy proteins, potentially expanding its market reach and product line.
The partnership with Vivici is likely to be viewed positively as it represents an expansion into a new product line and potential revenue stream for Ginkgo Bioworks. The collaboration could lead to increased investor interest and a potential uplift in the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80